/PHR.WA
PHR.WA Stock - Pharmena S.A.
Healthcare|BiotechnologyWSE
$2.55-1.54%
$0.04 (-1.54%) • Dec 23
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.5
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.81
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PHR.WA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.52 – $2.58
TARGET (TP)$2.93
STOP LOSS$2.35
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.47
52W High$4.79
52W Low$2.52
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $268,000 | $9.84M | $299,000 | $15.21M | $9.93M |
| Gross Profit | $198,000 | $5.84M | $10.34M | $7.83M | $5.08M |
| Gross Margin | 73.9% | 59.4% | 3456.5% | 51.5% | 51.2% |
| Operating Income | $-3,397,000 | $34.87M | $-508,000 | $-3,983,000 | $-6,035,000 |
| Net Income | $-1,262,000 | $28.94M | $-1,570,000 | $-4,592,000 | $-6,891,000 |
| Net Margin | -470.9% | 294.2% | -525.1% | -30.2% | -69.4% |
| EPS | $-0.11 | $2.60 | $-0.14 | $-0.41 | $-0.63 |
Company Overview
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PHR.WABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.04
Q2 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | — | — | — | — |
Q4 2025 | Nov 24, 2025 | — | — | — | — |
Q2 2025 | May 26, 2025 | — | $-0.04 | — | — |
Q1 2025 | Feb 26, 2025 | — | $-0.01 | — | — |
Q4 2024 | Nov 25, 2024 | — | $-0.04 | — | — |
Q3 2024 | Aug 26, 2024 | — | $-0.08 | — | — |
Q2 2024 | May 27, 2024 | — | $0.02 | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.04 | — | — |
Q4 2023 | Nov 27, 2023 | — | $2.71 | — | — |
Q3 2023 | Aug 25, 2023 | — | $-0.05 | — | — |
Q2 2023 | May 26, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.08 | — | — |
Q4 2022 | Nov 25, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.04 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.14 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.05 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.17 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.05 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.31 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PHR.WA
What is PHR.WA's current stock price?
Pharmena S.A. (PHR.WA) is currently trading at $2.55 per share. The stock has moved -1.54% today.
What is the analyst price target for PHR.WA?
No analyst price targets are currently available for this stock.
What sector is Pharmena S.A. in?
Pharmena S.A. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the WSE exchange.
What is PHR.WA's market cap?
Pharmena S.A. has a market capitalization of $0.03 billion, making it a small-cap company.
Does PHR.WA pay dividends?
No, Pharmena S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADV.WA
Adiuvo Investments S.A.
$0.50
Mkt Cap: $0.0B
AWM.WA
Airway Medix S.A.
$0.33
Mkt Cap: $0.0B
BMX.WA
BioMaxima S.A.
$11.10
Mkt Cap: $0.0B
GMT.WA
Genomtec S.A.
$3.77
Mkt Cap: $0.1B
MAB.WA
Mabion S.A.
$6.95
Mkt Cap: $0.1B
MOC.WA
Molecure S.A.
$6.36
Mkt Cap: $0.1B
NNG.WA
NanoGroup S.A.
$2.60
Mkt Cap: $0.1B
PTG.WA
Poltreg S.A.
$24.60
Mkt Cap: $0.1B
PUR.WA
Pure Biologics Spólka Akcyjna
$3.70
Mkt Cap: $0.0B
URT.WA
Urteste S.A.
$40.00
Mkt Cap: $0.1B
Explore stocks similar to PHR.WA for comparison